Three days of home BP monitoring good enough for detecting hypertension Dr. Kamal Kant Kohli20 Sept 2023 11:00 AM ISTUSA: A recent study has revealed that in most people, high home blood pressure (BP) can be excluded or identified with a high degree of confidence in...
COVID-19 treatment in outpatient settings: ACP Updates rapid practice points Dr. Kamal Kant Kohli20 Sept 2023 10:00 AM ISTUSA: A recent paper published in Annals of Internal Medicine presents the American College of Physicians's (ACP's) living, rapid practice points...
Exposure to indoor smoking, poor household conditions may increase risk of developing pediatric tuberculosis Dr. Kamal Kant Kohli20 Sept 2023 10:00 AM ISTManipal: A systematic review and meta-analysis, published in the European Journal of Pediatrics has shed light on the risk factors for the development...
Optimal Cervical Dilatation of 6 cm Linked to Decreased Cesarean Delivery Incidence Dr Nirali Kapoor20 Sept 2023 9:45 AM ISTTraditionally, labour can be divided into 3 stages, and the first stage is further subclassified into latent and active phases. A cervical dilation...
Metronidazole reasonable treatment option for patients with symptomatic oral lichen planus Medha Baranwal20 Sept 2023 9:45 AM ISTUSA: A recent study published in Clinical and Experimental Dermatology has shown metronidazole to be a reasonable option for patients with symptomatic...
Positive Fluid Balance Linked to Acute Kidney Injury and Mortality in Sepsis Patients Dr.Niharika Harsha B19 Sept 2023 8:00 PM ISTA recent retrospective study chart review shed light on the association between fluid balance, acute kidney injury (AKI), and mortality in sepsis and...
Noninvasive finger sweat testing may help monitor drug adherence among antipsychotic patients Dr. Kamal Kant Kohli19 Sept 2023 8:00 PM ISTUK: Scientists have now discovered a way to test the levels of common antipsychotic drugs in the sweat from patients fingerprints, offering a quicker,...
Momelotinib receives FDA approval for patients of myelofibrosis with anaemia Dr. Kamal Kant Kohli19 Sept 2023 8:00 PM ISTUSA: JAK inhibitor momelotinib (Ojjaara) has received approval from the US Food and Drug Administration (FDA) as the first therapy specifically for...
Elexacaftor-tezacaftor-ivacaftor therapy provides relief from chronic rhinosinusitis in patients with cystic fibrosis: JAMA Dr. Kamal Kant Kohli19 Sept 2023 8:00 PM ISTUSA: Treatment with elexacaftor-tezacaftor-ivacaftor (ETI; Trikafta) therapy is associated with improved chronic sinus disease and clinical outcomes...
Increased sedentary time linked with elevated risk of dementia in older adults Dr. Kamal Kant Kohli19 Sept 2023 8:00 PM ISTAdults aged 60 and older who spend more time engaging in sedentary behaviors like sitting while watching TV or driving may be at increased risk of...
Fall in death rates after first heart attack in people without diabetes, or with type 2 diabetes, not for type 1 diabetes Dr. Kamal Kant Kohli19 Sept 2023 8:00 PM ISTSweden: A recent study revealed falls in the death rates of both people without diabetes and those with type 2 diabetes, but not those with type 1...
Evinacumab effective and well tolerated for LDL cholesterol lowering in refractory hypercholesterolemia patients: JAMA Medha Baranwal19 Sept 2023 11:30 AM ISTUSA: A recent study published in JAMA Cardiology has demonstrated the potential utility of evinacumab as an effective and generally well-tolerated...
